These new findings suggest that an individual's BMI should be considered when selecting anti-hypertensive medications, he said.
"Treatment with calcium channel blockers appears preferable to treatment with diuretics in non-obese men and women with hypertension," Fonarow said.
The study was funded by Novartis Pharmaceuticals, maker of Lotensin.
More information
For more information on high blood pressure, visit the American Heart Association.
Copyright © 2012 HealthDay. All rights reserved.
Reader Comments (